Kaitlyn M. Morabito - Concepedia

Author

Kaitlyn M. Morabito

National Institute of Allergy and Infectious Diseases ORCID

Also Known As

Bob C. Lin, K M Morabito, K.M. Morabito, Kaitlyn M Morabito, Kaitlyn M. Morabito, Kaitlyn Morabito

Publications

9.6K

Citations

H-Index

Concepts

All Affiliations

National Institute of Allergy and Infectious Diseases National Institutes of Health Moderna Therapeutics (United States)George Washington University The University of Texas at Austin

About

Kaitlyn M. Morabito is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	2.2K
2	Immunology	11	11	2.2K
3	Allergy	3	3	215
4	Cell Biology	2	2	115
5	Microbiology	1	1	78

Kaitlyn M. Morabito

Publications

8.7K

Citations

H-Index

Page 1

	Year	Citations
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael, New England Journal of Medicine	2020	3.4K
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness Kizzmekia S. Corbett, Darin K. Edwards, Sarah R. Leist, Nature VaccinationPrototype Pathogen PreparednessVaccine DevelopmentImmunologyVirology	2020	1.6K
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates Kizzmekia S. Corbett, Barbara J. Flynn, Kathryn E. Foulds, New England Journal of Medicine	2020	1.1K
Rapid development of a DNA vaccine for Zika virus Kimberly A. Dowd, Sung‐Youl Ko, Kaitlyn M. Morabito, Science	2016	400
A proof of concept for structure-based vaccine design targeting RSV in humans Michelle C. Crank, Tracy J. Ruckwardt, Man Chen, Science	2019	323
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials Martin R. Gaudinski, Katherine V. Houser, Kaitlyn M. Morabito, The Lancet	2017	298
A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage Chao Shan, Antonio E. Muruato, Brett W. Jagger, Nature Communications	2017	143
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness Kizzmekia S. Corbett, Darin K. Edwards, Sarah R. Leist,	2020	142
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge Anthony DiPiazza, Sarah R. Leist, Olubukola M. Abiona, Immunity VaccinationVaccine DevelopmentImmunologyAntiviral ResponseSars-cov-2 Challenge	2021	100
Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung Kaitlyn M. Morabito, T.R. Ruckwardt, Alec Redwood, Mucosal Immunology	2016	99

Page 1